{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:53:48Z","timestamp":1758815628445},"reference-count":3,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/cmr.0000000000000074","type":"journal-article","created":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T10:45:18Z","timestamp":1397731518000},"page":"401-403","source":"Crossref","is-referenced-by-count":18,"title":["Four cases of rituximab-associated melanoma"],"prefix":"10.1097","volume":"24","author":[{"given":"Charles","family":"Velter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Pag\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Osio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Brice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9leste","family":"Lebb\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210129","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/art.22864","article-title":"Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study.","volume":"56","author":"Wolfe","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R2-17-20210129","doi-asserted-by":"crossref","first-page":"f1939","DOI":"10.1136\/bmj.f1939","article-title":"Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.","volume":"346","author":"Raaschou","year":"2013","journal-title":"BMJ"},{"key":"R9-17-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.18632\/oncotarget.437","article-title":"Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells.","volume":"3","author":"Schlaak","year":"2012","journal-title":"Oncotarget"}],"container-title":["Melanoma Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CMR.0000000000000074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:16:59Z","timestamp":1621887419000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008390-201408000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":3,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cmr.0000000000000074","relation":{},"ISSN":["0960-8931"],"issn-type":[{"value":"0960-8931","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}